Avalo Therapeutics (AVTX) Receivables - Other (2017 - 2024)
Avalo Therapeutics (AVTX) posted Receivables - Other of -$387000.0 for Q4 2024, down 138.78% on a QoQ basis from $998000.0 in Q3 2024, and up 72.4% year-over-year from -$224482.4 in Q1 2024.
Avalo Therapeutics (AVTX) Receivables - Other (2017 - 2024) Analysis & Trends
Avalo Therapeutics' Receivables - Other history runs 8 years deep, the most recent figure standing at -$387000.0 for Q4 2024.
- Quarterly Receivables - Other rose 72.4% year-over-year to -$387000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$3.0 million (up 28.92% YoY) and the FY2024 annual result came in at $611000.0, up 134.27% from the prior year.
- Receivables - Other was -$387000.0 for Q4 2024 at Avalo Therapeutics, down from $998000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $2.5 million in Q3 2021 and bottomed at -$2.3 million in Q1 2022.
- A 5-year average of $574300.8 and a median of $998000.0 in 2021 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2020 — Receivables - Other jumped 3477.07% — and 2024, when it tumbled 1766.67%.
- Avalo Therapeutics' Receivables - Other stood at -$2.1 million in 2020, then surged by 160.76% to $1.3 million in 2021, then tumbled by 52.06% to $605000.0 in 2022, then sank by 331.74% to -$1.4 million in 2023, then surged by 72.4% to -$387000.0 in 2024.
- Business Quant data shows AVTX's Receivables - Other at -$387000.0 in Q4 2024, $998000.0 in Q3 2024, and -$100000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -387,000.00 |
| Dec 31, 2024 | -387,000.00 |
| Sep 30, 2024 | 998,000.00 |
| Sep 30, 2024 | 998,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Jun 30, 2024 | -100,000.00 |
| Mar 31, 2024 | -101,000.00 |
| Mar 31, 2024 | -101,000.00 |
| Dec 31, 2023 | -1.40 Mn |
| Dec 31, 2023 | -1.40 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Sep 30, 2023 | 1.54 Mn |
| Jun 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | -1.06 Mn |
| Mar 31, 2023 | -1.06 Mn |
| Dec 31, 2022 | 605,000.00 |
| Dec 31, 2022 | 605,000.00 |
| Sep 30, 2022 | 1.31 Mn |
| Sep 30, 2022 | 1.31 Mn |